Setting new standards in information exchange for the pharmaceutical and biotech industry
Mark Simon, Torreya Partners Discusses Business Aspects of Immuno-Oncology with Valerie Bowling, Conference Forum
March 20, 2016
Valerie Bowling, Conference Forum sat down with Mark Simon to discuss the business aspects of Immuno-Oncology at the IO360° conference. Mark gives insights into the challenges of intellectual capital vs financial capital, prioritizing combinations, consolidation in the industry, the future of vaccines and more.
Watch the full interview below.
Mark Simon moderated our “sensational seven” panel dedicated to business aspects of immuno-oncology at the IO360° conference, which took place in February 2016 in NYC. For more information about the IO360° conference, please click here.
The next scheduled conference in the Imunno-Oncology space is Rational Combinations 360° which will take place June 23-24,2016 in New York City.